Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

Federica Tomao, Anselmo Papa, Luigi Rossi, Davide Caruso, Federica Zoratto, Pierluigi Benedetti Panici, Silverio Tomao
  • Expert Opinion on Investigational Drugs, October 2013, Informa Healthcare
  • DOI: 10.1517/13543784.2013.839657
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Federica Tomao

In partnership with: